Robert Andrade

Robert Andrade appears in our data through filings on Fennec Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 21 September 2022 to 12 October 2026, the count stands at 50 filings.

Both buying and selling appear: 1 purchase, against 6 sales worth €1.4M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 31 share grants and 12 option exercises. 2026 to date brings no purchases and 1 sale.

Most recently, on 13 October 2026, the filings show a share grant worth €19k in Fennec Pharmaceuticals Inc. The last purchase on record was published on 3 April 2024, which is 928 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.